Research and Development
Listen: Adapting to Change
Podcast features bleeding disorder experts in celebration of World Hemophilia Day.
Boosting Young Scientists
CSL Behring in Bern, Switzerland, awards scholarships to three top students.
NFL Players Cheer On Rare Disease Research
Uplifting Athletes presents $140,000 in research grants in the Young Investigator Draft.
Calling All Innovators
Your inventive idea could help the growing number of patients who rely on plasma-derived immunoglobulin.
What Is Convalescent Plasma?
Antibody-rich blood component may hold potential for those battling COVID-19.
Drafting Future Research Stars
On March 30, watch the Uplifting Athletes Young Investigator Draft to show support for scientists working to unravel rare dis…
Explainer: What Are Natural History Studies?
Natural history studies collect information from patients to better understand diseases, especially rare ones.
At the Heart of Innovation for Patients
Marburg, Germany’s vibrant R&D ecosystem creates hope for patients and CSL Behring’s future.
Expanding U.S. Cell- and Gene-Therapy Capability
CSL Behring’s planned laboratory in California will enhance innovation and collaboration near academic and research instituti…
Writing the Book on Sickle Cell Disease
Dr. Greg Kato, a CSL Behring medical expert, is among three editors of a new, deeply researched text on sickle cell disease. …
A Research Catalyst in Switzerland
A new partnership between CSL Behring and Biopôle takes shape, pairing the global biotech with one of the most dynamic life s…